Created in July 2009 and based in the Atalante Saint-Malo Science Park, KELIA is a subsidiary company of CELLIS PHARMA Group.

This French Pharmaceutical company is specialized in discover of new drugs in the fields of Cancer and Metabolic diseases.

Several projects are developed, and our major aim is to find new natural therapeutic molecules which present more benefic effects than actual drugs without secondary damages.

Actually, KELIA is constituted by nine collaborators, and is directed by Drs Elise Duval and Amandine Baron.

Its development is co-supported by Oséo, Brittany region and Saint-Malo Agglomération.

KELIA has access to laboratory facilities constituted of 400 m² with specific confinement.

KELIA will be present at European Cancer Cluster, 14-16 Septembre, 2011, Toulouse - France

. http://www.bretagne-innovation.tm.fr/innover/actualites/fiche.php?actualite_id=3536

. http://www.stmalo-agglomeration.fr/tl_files/client/st_malo_agglo/Newsletter/PDF_Newsletter/Newsletter8.pdf